Improving eye surface health before cataract surgery with Systane COMPLETE
Official title: Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery
Run by National Taiwan University Hospital · NCT06763731 · Data updated 2026-11-12
This study tests if using Systane COMPLETE can help people with dry eyes feel better before cataract surgery and improve their surgery results.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 20 Years to 85 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei, Taiwan) |
| Status | Recruiting |
| Started | May 2, 2024 |
| Main results expected | January 14, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | April 23, 2026 |
| Trial ID | NCT06763731 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 20-85 with mixed dry eye who require cataract surgery.
✕Probably not a fit
Patients with significant ocular surface abnormalities or those currently using dry eye medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effects of regular use of Systane COMPLETE in patients with mixed dry eye who are preparing for cataract surgery. The objective is to determine how this treatment may optimize the ocular surface and improve predictions of residual astigmatism post-surgery. Participants aged 20-85 will be monitored for their ability to answer questionnaires and undergo pre-operative assessments. The study aims to enhance surgical outcomes by addressing dry eye symptoms prior to the procedure.
Why it matters
Potential benefit: If successful, this approach could lead to improved surgical outcomes and visual acuity for patients undergoing cataract surgery.
How similar studies have gone: Other studies have shown positive outcomes with similar interventions in optimizing ocular surface health before surgery.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: The subjects aged 20-85 years, with normal cognitive function and capable of answering related questionnaires who require phacoemulsification and intraocular lens implantation under topical anaesthesia, are the eligible candidates. Exclusion Criteria: 1. Unable to answer the questions in the dry eye survey. 2. Ocular trauma or ocular surgery in the planned surgical eye, active ocular infection, and obvious abnormalities in ocular surface or eyelid margins other than MGD cause decreased visual acuity other than cataracts. 3. Dry eye signs: Corneal Fluorescein Staining CFS (+) to exclude any corneal abnormalities or epithelial defect 4. Systemic drug use, including tetracycline derivatives, antihistamines, and isotretinoin. 5. Using dry eye medication at screening stage
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan, Taiwan Recruiting
Study contacts
- Study coordinator: Chiun Ho Hou, Ph.D
- Email: chiunhohou@gmail.com
- Phone: +88623123456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tropicamide/phenylephrine safety in hospitalized patients
This project will see if certain health factors make hospitalized adults more likely to have side effects after getting tropicamide/phenylephrine eye drops.
-
Identification of Cellular Biomarkers in Rare Eye Diseases
This study tests whether specific gene and protein markers in cells and tears can distinguish adults with rare corneal diseases from others and relate to their eye symptoms.
-
Using Systane COMPLETE to improve dry eye symptoms before and after cataract surgery
This study is testing if using Systane COMPLETE eye drops can help people with dry eyes feel better before and after cataract surgery.
-
Using oral anti-anxiety medication during second eye cataract surgery
This study is testing if taking the anti-anxiety medication XANAX can help people feel less anxious and more comfortable during their second eye cataract surgery compared to a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.